司美格鲁肽和替拉帕肽是先进的每周一次注射药物，可通过调节食欲、血糖和新陈代谢来帮助减肥。

Semaglutide works on one hormone (GLP-1) to control appetite, while Tirzepatide targets two (GLP-1 and GIP), often leading to enhanced weight loss results for some patients.

根据药物、剂量和生活习惯的不同，患者随着时间的推移平均可以减轻 10% 至 25% 的体重。

Both Semaglutide and Tirzepatide are administered once weekly. Many patients choose convenient at-home self-injections after guidance.

Yes. For optimal, long-term results, these treatments should be combined with a healthy diet and regular physical activity. We provide personalized guidance.